Shanghai InnoStar Bio-tech Co., Ltd. (SHA:688710)

China · Delayed Price · Currency is CNY

77.87

+12.98 (20.00%)

At close: Jul 10, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Medical Labs & Research	811.33M	1.14B	1.04B	863.07M	-
Medical Labs & Research Growth	-28.94%	9.94%	20.32%	-	-
Total	811.33M	1.14B	1.04B	863.07M	-
Total Growth	-28.94%	9.94%	20.32%	-	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
China	761.52M	1.12B	-	-	-
China Growth	-31.83%	-	-	-	-
Overseas	49.81M	24.55M	-	15.20M	-
Overseas Growth	102.91%	-	-	-	-
South China	-	-	-	39.33M	-
North China	-	-	-	85.91M	-
Southwest	-	-	-	44.59M	-
Central China	-	-	-	3.06M	-
Northwest	-	-	-	5.22M	-
Northeast	-	-	-	23.49M	-
East China	-	-	-	645.42M	-
Total	811.33M	1.14B	-	862.21M	-
Total Growth	-28.94%	-	-	-	-